TG THERAPEUTICS, INC.: operating_income
| Value | {"amount": -169055000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:09.723465+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/eb8ed771-0eec-44a2-a9ef-900e98818558
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-20-001897Retrieved: 2026-08-19T09:42:09.723465+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/operating-income/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/eb8ed771-0eec-44a2-a9ef-900e98818558
History
- no predecessors — first report